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Abstract
Purpose: Invasive amebiasis is an emerging parasitic disorder in Taiwan, especially in patients
diagnosed with human immunodeficiency virus (HIV) infection. Thirty-three Taiwanese subjects
with amebic liver abscess (ALA) were examined and a possible correlation between ALA and HIV
infection was investigated.
Results: Among ALA patients, the proportion of HIV-positive individuals increased during the
study period. ALA was the first major clinical presentation in 54% of HIV patients with ALA.
Overall, 58% (14/24) of HIV-infected patients had a CD4+ count > 200 cells/μL and 82.1% (23/28)
had no concurrent opportunistic infection or other evidence of HIV infection. There was no
marked difference in clinical characteristics between HIV-positive and HIV-negative ALA patients
except the level of leukocytosis.
Conclusion: While the clinical characteristics described herein cannot be used to determine
whether ALA patients have HIV infection, routine HIV testing is recommended in patients with
ALA, even in the absence of HIV symptoms.
Background
Amebiasis, a parasitic infection caused by Entamoeba histo-
lytica, is transmitted by ingestion of food or water contain-
ing the cyst form of the parasite, and results in amebic
colitis and the formation of amebic liver abscess (ALA).
Amebiasis is one of the most infectious diseases in the
world with developing countries, including Central and
South America, tropical Asia, and Africa, as areas of high-
est incidence. In developed countries, individuals at
increased risk for amebiasis include immigrants from
developing countries, travelers to the tropics, residents of
institutions for mentally retarded individuals, homosex-
ual men, and immunodepressed individuals. Patients
with advanced human immunodeficiency virus (HIV)
represent one of the highest risk groups of invasive ame-
biasis [1,2]. Luminal agents such as paromomycin, diloxa-
nide furoate, and iodoquinol are typically used for the
treatment of amebiasis caused by E. histolytica infection
[1].
ALA is the most common extraintestinal manifestation of
E. histolytica infection. E. histolytica transmission is associ-
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sanitary conditions [3]. Traveling to endemic areas, with
the possibility of ingesting contaminated food or water,
remains a risk for contracting ALA. In Taiwan, the
improved sanitary system has decreased invasive amebic
infection to less than one case per year [4-6]. However, the
reappearance of ALA after 1995 appears to be closely asso-
ciated with HIV infection. The proportion of recent cases
of ALA with underlying HIV infection increased markedly.
Recently, Hung et al. have noted that invasive amebiasis
has become an emerging parasitic disease in HIV-infected
patients in Taiwan [4,5]. The characteristics of ALA in Tai-
wan remain unknown. Therefore, we conducted a retro-
spective study to identify the characteristics of ALA and
the relationship with HIV infection in Taiwan.
Methods
Patients and data collection
Patients who were diagnosed with ALA at the National
Taiwan University Hospital (a 2500-bed university hospi-
tal and largest referral center for HIV/AIDS in Taiwan)
were enrolled from March 1, 1990 to February 28, 2006 in
this retrospective study. Detailed medical records, includ-
ing demographic data, disease status, clinical presenta-
tion, risk factors of HIV infection, laboratory findings,
treatment, and outcome were reviewed. CD4 count,
plasma viral load, and concomitant opportunistic infec-
tion(s) records were analyzed if HIV infection was diag-
nosed. The study described herein was approved by the
Institutional Review Board and was in accordance with
the Declaration of Helsinki.
Diagnostic criteria
Study patients were considered to have ALA if image stud-
ies had demonstrated the presence of intra-hepatic
abscesses and were accompanied with histological, sero-
logical, or clinical evidence of amebic infection [4-6].
Three typical conditions were classified as ALA. First,
patients with histological evidence of erythrophagocytic
trophozoites identified in aspirates or biopsy tissue were
diagnosed with ALA. Second, patients with a titer over
1:128 in the indirect haemagglutination (IHA) serologic
assay were also included in the group of ALA cases. Third,
patients without underlying biliary tract disease who
responded well to metronidazole monotherapy, but had
positive image studies were also considered as ALA cases,
even if their serum IHA titer was less than 1:128 (because
the IHA titer assay only has an intermediate sensitivity).
Patients who responded well to metronidazole mono-
therapy were defined as those individuals in which fever
or other clinical symptoms/signs improved after 3 days of
metronidazole monotherapy. In addition, patients who
had specimen such as blood or aspiration fluid with fun-
gus or bacteria pathogens that were concomitantly iso-
lated, were excluded from this study to avoid the
enrolment of patients with mixed infection. If ALA
recurred during the study period, data for the first time
diagnosis was collected.
Patients were considered to have concomitant amebic col-
itis if trophozoites were found in stools or biopsy speci-
mens from colon fibroscopic examination.
Statistical analysis
Statistical analyses were performed using SPSS 10.0 for
Windows (SPSS, Chicago, Illinois). Statistical significance
of continuous variables was determined by using a non-
parametric test (Mann-Whitney U test) and categorical
variables were determined using the Fisher's exact test. All
tests were two-tailed and P < 0.05 was considered statisti-
cally significant. Continuous variables were reported as
mean ± standard deviation (SD).
Results
Increase in HIV infection in ALA patients
During the study period, 37 patients met the diagnostic
criteria for ALA. HIV serum test results were obtained in
33 patients. Five (15.2%) patients had negative HIV test
results and 28 (84.8%) patients were HIV-positive.
Between 1990 and 1994, there was only one case of ALA
every year; most patients had an unknown HIV infection
status. In 1995, three cases of ALA were recorded, two of
which had HIV-coinfection. Since then, the number of
ALA cases increased gradually. In 1999, six patients had
ALA, with five (82.4%) being coinfected with HIV. After
2002, the rate of ALA patients coinfected with HIV
increased to 100% (9/9) (Figure 1). This significant
increase prompted us to determine the characteristics of
ALA patients with and without HIV infection.
Demographic characteristics of patients with and without 
HIV infection
The demographic characteristics of patients with and
without HIV infection are listed in Table 1. The mean age
was 44.2 ± 10.3 years in HIV-negative patients and 36 ±
10.1 years in HIV-infected patients. No female patients
were included in either of the above mentioned groups.
The five HIV-negative patients had a history of traveling to
or living in endemic areas, including Thailand (n = 1),
Burma (n = 2), Pakistan (n = 1), and the Philippines (n =
1). Of the 28 HIV-infected patients, four (14%) had
traveled to Thailand within one month of the ALA epi-
sode, and 24 (86%) had a history of homosexual behav-
ior. Remarkably, more than half (15/28, 54%) of the HIV-
infected ALA patients were found to have HIV infection
after they were diagnosed with ALA. Ten (36%) patients
developed ALA after HIV had been diagnosed (2 months
to 10 years later). The remaining three (10%) patients
were found to be HIV-infected 4 months to 3 years afterPage 2 of 5
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diagnosed with HIV infection during the second recur-
rence of ALA while the other two were diagnosed with HIV
infection during other opportunistic infection episodes.
Of the 28 HIV-infected patients, nine (32%) were hepati-
tis B virus (HBV) carriers and four (14%) were hepatitis C
virus (HCV) carriers. One patient was co-infected with
HBV and HDV (hepatitis D virus), and another patient
was co-infected with HBV and HCV. Serum Venereal Dis-
ease Research Laboratory (VDRL) examination was also
positive in 12 (43%) of the HIV-infected patients.
Significant clinical manifestations
Fever (>38°C) was the most common clinical symptom in
ALA patients (100% in the HIV-negative group and 64%
in the HIV-infected group, P = 0.29). Other symptoms
included abdominal pain (40% in the HIV-negative group
and 57% in the HIV-infected group, P = 0.64) and
diarrhea (20% in the HIV-negative group and 36% in the
HIV-infected group, P = 0.64). Four patients initially pre-
sented with right-flank pain and were treated inappropri-
ately for urinary tract infection. The correct diagnosis was
obtained later after treatment failed and after image stud-
ies were obtained. Some non-specific complaints
included cough (n = 6), abdominal fullness (n = 3), ano-
rexia (n = 3), body weight loss (n = 3), and general
malaise (n = 3).
Seven patients had amebic colitis diagnosed at the same
time (two in the HIV-negative group; five in the HIV-
infected group). Five patients were diagnosed with histo-
logical findings of amebic trophozoites (four patients via
colonoscopy biopsy, one via laparotomy biopsy).
Another two patients had trophozoites in their stool spec-
imens. Three patients also had peritonitis complication
(one in the HIV-negative group; two in the HIV-positive
group). One case of peritonitis was caused by liver abscess
rupture and the other case was caused by colitis rupture.
None of these patients had empyema, pericarditis, or
brain abscess complications.
Laboratory Examinations
All five HIV-negative ALA patients had IHA titers over
1:128 (from 1:512 to 1:16,384). Of the 28 HIV-infected
patients, 24 had IHA titers over 1:128 at the onset of ALA.
Four HIV-infected patients had IHA titers remaining
below 1:64 during the entire treatment course, but had
typically good responses to metronidazole monotherapy.
All patients showed leukocytosis, but the mean white
blood cell count in HIV-negative patients was significant
higher than that in HIV-infected patients (19,476 ± 9,363/
μL [range: 12,930–36,040] versus 11,982 ± 7,854/μL
[range: 3,420–38,140], P = 0.02). The AST and ALT levels
were elevated 3- to 5-fold in HIV-negative patients and 1-
to 2-fold in HIV-infected patients, but was not statistically
different between the two groups. Both groups had a 2-
fold elevation in alkaline phosphate levels (376 ± 324 U/
L versus 337 ± 175 U/L). Bilirubin and platelet levels,
however, were within normal limits for both groups (i.e.,
220 ± 100 K/μL for the platelet level; 0.2–1.2 mg/dL for
the bilirubin level).
In the HIV-infected group, the mean CD4 count (data of
24 patients) was 266.95/μL (14 to 798/μL) at the time of
ALA diagnosis. Five patients had CD4 counts higher or
equal to 350/μL (20%). Nine patients had CD4 counts
between 200 and 349/μL (38%). Ten patients (42%) had
CD4 counts below 200/μL. Plasma viral loads (data of 18
patients) ranged from undetectable levels (< 400 copies/
mL) to > 750,000 RNA copies/mL. Further comparison
between patients with IHA titers > 1:128 and patients with
IHA titers < 1:64 revealed no significant different in the
distribution of CD4 (P = 0.39) (Table 2). Five patients
developed an opportunistic infection at the same time.
One patient had a hairy leukoplakia and his CD4 count
was 223/μL. The other four patients had oral candidiasis
and their CD4 counts were 14/μL, 84/μL, 229/μL, and
367/μL, respectively.
Cases of ALA at the National Taiwan University Hospital from 1990 to 2005Figure 1
Cases of ALA at the National Taiwan University Hos-
pital from 1990 to 2005. White bars represent ALA 
patients with unknown HIV status; light-gray bars represent 
HIV-negative ALA patients; dark gray bars represent HIV-
positive ALA patients. The proportion of HIV-infected 
patients among all cases of ALA increased significantly (0% → 
62.5% → 82.3% → 100%; P = 0.005 by 2 × 4 Chi-square anal-
ysis).Page 3 of 5
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All patients had a good response to metronidazole mono-
therapy; the mean treatment duration was 14.9 days
(range: 7–33 days; 17 ± 3.7 days in HIV-negative patients
and 14.4 ± 5.6 days in HIV-infected patients). Eradication
therapy with idoquinol was also used in one (20%) HIV-
negative patient and 22 (79%) HIV-infected patients (one
of whom did not receive idoquinol during the first infec-
tion but only when the infection recurred).
The condition of the patients during hospitalization was
benign, and all patients were alive at the time of discharge.
Follow-up was generally uneventful. ALA recurred in only
three patients (one HIV-negative patient and two HIV-
positive patients). Of the two HIV-infected patients who
had recurrence of ALA, one never received eradication
therapy with idoquinol in the first episode. In addition,
one patient had recurrent amebic colitis, but no liver
abscess despite receiving eradication therapy with idoqui-
nol during the first infection episode.
Discussion
In the present study, all HIV-infected patients were male.
The major risk for acquiring ALA could be attributed to
the homosexual behavior (86% in this study). The oral-
anal contact renders patients prone to be infected by ame-
bas [4,7,8]. Although studies performed in North America
and Europe demonstrated a high rate of ameba carriers
Table 1: Characteristics of ALA in patients with or without HIV infectiona
HIV-negative (n = 5) HIV-Infected (n = 28) P value
Mean age, years 44.2 ± 10.3 (30–57) 36 ± 10.1 (23–70)
Male/Female 5/0 28/0 1
IHA titer 512–16384 <8–16,384
Underlying diseases
Diabetes mellitus 20% (1) 0 (0) 0.15
HBV hepatitis 20% (1) 32% (9) 1
HCV hepatitis 0 (0) 14% (4) 1
Risk factors
Endemic traveling 80% (4) 14% (4) 0.08
Clinical manifestation
Fever 100% (5) 64% (18) 0.29
RUQ pain 40% (2) 57% (16) 0.64
Diarrhea 20% (1) 36% (10) 0.64
Right flank pain 20% (1) 11% (3) 0.5
Concurrent colitis 40% (2) 18% (5) 0.28
Laboratory data
IHA titer 1:512 ~1:16,384 1:8~1:16,384
WBC/μL 19,476 ± 9,363 11,982 ± 7,854 0.02
GOT U/L 156 ± 251 52 ± 44 0.94
GPT U/L 106 76 ± 124 0.30
Alkaline phosphatase, U/L 376 ± 324 337 ± 175 0.46
Complications
Peritonitis 0% (0) 11% (3) 1
Pleural effusions 0% (0) 18% (5) 0.57
Treatment
Mean Metronidazole use duration (days) 16.8 ± 3.7 14.4 ± 5.6 0.17
Follow-up with idoquinolone 20% (1) 79% (22) 0.01
Outcome
Recurrence of ALA 20%(1) 7.1% (2) 0.4
Mortality 0% (0) 0% (0)
aData are presented as mean ± SD, % (n), or range
Table 2: CD4 distribution in HIV-infected cases of ALA with available data of CD4+ cell count
IHA titer ≥ 128 (n = 20) IHA titer ≤ 64 (n = 4)
Mean CD4/μL 237.24 415.5
CD4 ≥ 350/μL 3 2
CD4 349 to 201/μL 8 1
CD4 ≤ 200/μL 9 1Page 4 of 5
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were rare in these reports [2,9-11]. Nevertheless, similarly
to the present study, recent studies performed in Asia
revealed that invasive amebic diseases occur more often in
homosexuals, especially in those homosexual individuals
that are coinfected with HIV [2,4,6-8,12]. Whether this is
due to the geographic distribution of different zymo-
demes of ameba, to the homosexual behavior, or to a sup-
pressed host response to E. histolytica deserves further
study [6]. In addition, some studies suggested that host
factors, such as dysregulation of T-cell activity, may also
play an important role in HIV-infected patients who are
susceptible to invasive amebiasis [2,6].
Previous reports have shown that abdominal pain and
fever are two typical clinical symptoms that develop in
over 85% patients with ALA [3]. In the present study, we
discovered that both fever and abdominal pain occurred
less frequently than reported in the literature, especially in
HIV-infected ALA patients. Furthermore, we noted that
ALA patients coinfected with HIV had a significantly lower
white blood cell count than HIV-negative patients. This
reduced systemic inflammatory response syndrome
(SIRS) may also be attributed to HIV infection. Therefore,
the lack of typical ALA symptoms in up to one-third of the
patients who participated in this study should alert the
physician that further image study may be necessary to
rule out ALA in HIV-infected patients with a poor
response to current treatment. Most importantly, we
showed that it is difficult to determine on the basis of the
clinical presentation whether a given patient with ALA
exhibits an underlying HIV infection.
In HIV-infected ALA patients, CD4 counts varied greatly
from 14 to 798/μL, suggesting that ALA is not caused by
an opportunistic infection. In addition, the recurrence of
ALA or amebic colitis in HIV patients was rare and was not
limited to those who did not receive idoquinol. Therefore,
we suggest that the most likely recurrence route was the
repeated practice of oral-fecal sex.
Based on our experience, ALA has a benign prognosis in
both HIV-negative and HIV-infected patients. A 14-day
metronidazole treatment with or without eradication
with idoquinol can generally result in a good clinical
response. There was no hospital mortality, even in
patients with opportunistic infections (n = 5). However,
there was a rare occurrence of peritonitis (three patients),
which could have been fatal if not adequately treated.
In conclusion, the proportion of HIV infection among
ALA patients increased significantly during the study
period. No obvious difference in clinical features between
HIV-infected and HIV-negative patients could be identi-
fied. ALA may be the first major clinical presentation in
HIV-infected patients. Most HIV-infected ALA patients
had no concurrent opportunistic infection or other evi-
dence of HIV infection. Although this study will need to
be expanded in the future including more ALA patients
with and without HIV infection, our results strongly sug-
gest that physicians should not rely on the clinical features
to determine whether ALA patients are infected with HIV
or not. In fact, routine HIV testing is recommended in
cases of ALA even in the absence of any clinical features
suggesting HIV infection.
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